Filter posts

Gene Patent Discussion Should Include Industrial, Environmental, & Ag Biotech

Twenty-three industrial and agricultural biotech companies, ranging from development-stage businesses to all of the largest …

India Compulsory License: A Times of India Article Says It's Not Helping the Poor

India recently issued a compulsory license on Bayer’s liver and kidney cancer drug (Sorafenib) with …

BIO IP Counsels Conference Agenda Topics

Join us in Austin for BIO’s Intellectual Property Counsels Committee Conference on April 16-18.  Agenda …

Brazilian Innovation: A Patent Success

The story of Acheflan highlights the role of patents in homegrown innovation in developing countries.  …

IPCC Features Update on Patent Reform Implementation

The BIO Intellectual Property Counsels Committee Fall Conference featured an update on the implementation of …

The Critical Importance of International Patent Protection for Small Businesses

As part of the implementation of the Leahy-Smith America Invents Act, the U.S. Patent and …

KORUS and BIO's New Senior Vice President for International Affairs

Earlier this week, Joseph Damond joined BIO as Senior Vice President of International Affairs.  He …

Data Protection, the Trans Pacific Partnership, and the US-Jordan FTA (Post 1 of 2)

The Trans Pacific Partnership (TPP) negotiation does not yet include a section on data protection …

Non-Communicable Diseases and IP?

On September 19 and 20, the United Nations meets to potentially adopt a declaration on non-communicable …

Global Biotechnology IP Evaluation by Scientific American

Scientific American evaluated the strength of intellectual property in 48 countries (click on chart on …